Absolutely delighted to join a fantastic team at CU Cancer Center! Thank you Breelyn Wilky, MD 🎗 for this exciting opportunity and Palma Dileo for being such a great mentor!

Bernd Kasper and ⁦Jean-Yves Blay⁩ at ⁦ESMO - Eur. Oncology⁩ just before the Presidential Symposium I, where the amazing results of the DeFi study of nirogacestat in #desmoid will be presented. JY very relaxed and Bernd a bit stressed out! Don’t worry Bernd! You’ll do great! ⁦

Save the Date! CTOS Webinar on Desmoid Fibromatosis October 20th Excited to announce the 1st CTOS Webinar that will kick off a series of webinars hosted by CTOS to promote disease-specific educational content. The webinar will focus on Desmoid, the 2022 Sarcoma of the Year.

Awesome local tumor management section of Nat'l LMS Foundation #researchroundtable22, surgical considerations, XRT, precision medicine…

Dr. Breelyn Wilky will present data on botensilimab, a novel innate/adaptive immune activator, +/-botensilimab in cold and IO refractory solid tumors at #TheRoadTaken. Make sure to register for the webcast! In person attendance is at capacity. Sign-up at: agenusbio.zoom.us/webinar/regist…